Mereo BioPharma Group plc Confidential and Anonymous Financial Concern Hotline
The SEC, in its final ruling regarding standards relating to Audit Committees, requires that Mereo BioPharma Group plc provide a facility for the receipt, retention and treatment of complaints received regarding accounting, internal accounting controls or auditing matters.
Please feel free to contribute any comments through this interface regarding such accounting matters. Your message is encrypted and will be delivered directly to the Audit Committee.
Understanding and acting upon any issues that exist regarding financial, accounting and/or audit matters is an essential component to Mereo BioPharma Group plc ability to take action and ensure the highest levels of financial fidelity.
You may leave a message using the Secure Web Form below
Click here to view frequently asked questions
Click here to file your case using a secure and encrypted web form.